Results 111 to 120 of about 29,640 (301)

Impression cytology in vernal conjunctivitis [PDF]

, 2004
PURPOSE: To study conjunctival surface changes caused by chronic inflammation in vernal keratoconjunctivitis using impression cytology. METHODS: Samples of conjunctival epithelium were collected from 30 patients with vernal keratoconjunctivitis and 30 ...
Barros, Jeison de Nadai, Camargo, Gustavo Bueno de, Lake, Jonathan Clive, Nishiwaki-dantas, Maria Cristina   +3 more
core   +3 more sources

Efficacy and Safety of Anti‐IL‐4Rα Stapokibart in Elderly Patients With Moderate‐To‐Severe Atopic Dermatitis

International Journal of Dermatology, EarlyView.
ABSTRACT Background Elderly patients with moderate‐to‐severe atopic dermatitis (AD) often exhibit more heterogeneous inflammatory profiles compared with younger adults. To evaluate the efficacy and safety of stapokibart, an anti‐interleukin‐4 receptor α subunit (IL‐4Rα) monoclonal antibody, in different age subgroups.
Yan Zhao, Litao Zhang, Liming Wu, Bin Yang, Jinyan Wang, Yumei Li, Qingchun Diao, Jingyi Li, Qing Sun, Xiaohong Zhu, Xiaoyong Man, Lihua Wang, Yanyan Feng, Tao Cai, Huiming Zeng, Linfeng Li, Jianyun Lu, Hong Ren, Fuqiu Li, Qianjin Lu, Xiaohua Tao, Rong Xiao, Chao Ji, Jing Sun, Yanping Qiu, Bo Chen, Jianzhong Zhang   +26 more
wiley   +1 more source

ANALISIS DESKRIPTIF JUMLAH EOSINOFIL MUKOSA KONJUNGTIVA DAN DERAJAT KONJUNGTIVITIS ALERGI BERDASARKAN 5-5-5 EXACERBATION GRADING SCALE [PDF]

, 2016
Hanani Kusumasari, G0012088, 2015. Analisis Deskriptif Jumlah Eosinofil Mukosa Konjungtiva dan Derajat Konjungtivitis Alergi Berdasarkan 5-5-5 Exacerbation Grading Scale. Skripsi.
Kusumasari, Hanani
core  

Minimal Disease Activity as A New Therapeutic Target in Atopic Dermatitis: A 5‐Year Real‐Life Experience With Dupilumab

International Journal of Dermatology, EarlyView.
ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease with significant physical and psychosocial burden. Dupilumab, a monoclonal antibody targeting IL‐4Rα, has proven to be effective for moderate‐to‐severe AD, but long‐term real‐world data remain limited.
Francesco Leo, Luca Mastorino, Luca Cangialosi, Davide Favre, Chiara Anna Fiasconaro, Yingying Liao, Federico Goso, Niccolò Siliquini, Giovanni Cavaliere, Pietro Quaglino, Simone Ribero, Michela Ortoncelli   +11 more
wiley   +1 more source

Treatment of patients with allergic conjunctivitis: experience of an outpatient ophthalmologist [PDF]

Клиническая офтальмология
G.A. Azamatova1, G.R. Altynbaeva2 1Bashkir State Medical University, Ufa, Russian Federation 2City Clinical Hospital No. 5 of the city of Ufa, Ufa, Russian Federation Allergic conjunctivitis (AC) is one of the common eye diseases.
G.A. Azamatova, G.R. Altynbayeva
doaj  

Frequency of Sensitization to Aeroallergens in Patients with Seasonal and Perennial Allergic Conjunctivitis

Revista Alergia México, 2014
Background: Allergic conjunctivitis is an in ammatory disease which involves the conjunctiva, its physiopathology is a type I hypersensitivity (IgE mediated). It is related to the sensitization to indoors and out- doors aeroallergens.
Guillermina Cortés-Morales, Andrea Aída Velasco-Medina, Mariana Esther Arroyo-Cruz, Guillermo Velázquez-Sámano   +3 more
doaj   +1 more source

Impaired sleep quality in children with allergic conjunctivitis and their parents [PDF]

, 2022
Jing Li, Shiyao Zhang, Zixin Fan, Ren Liu, Ling Jin, Lingyi Liang   +5 more
openalex   +1 more source

Health-related quality of life in food hypersensitive schoolchildren and their families: parents' perceptions [PDF]

, 2006
Background About 20% of schoolchildren and adolescents in Sweden suffer from perceived food hypersensitivity (e.g. allergy or intolerance). Our knowledge of how child food hypersensitivity affects parents HRQL and what aspects of the hypersensitivity ...
Birgitta Marklund, Staffan Ahlstedt, Gun Nordström, A Sandin, B Marklund, SH Sicherer, HA Aardoom, DJ Hill, C Pénard-Morand, T Schäfer, RD Ampon, M Hazell, JRC Rosenzweig, VJ Merikallio, MA Ben-Gashir, G Kiebert, KF Thomson, L Lundberg, MJ Derebery, SM Fineman, L Laforest, EO Meltzer, RD Annett, M Matheson, PO Ehrs, G Arslan, NJ Avery, SH Sicherer, MN Primeau, N Gunnarsson, JL Landgraf, H Raat, U Norrby, MI Asher, A Jokovic, C Eiser, NCM Theunissen, C Williams, ME Bollinger, D Korol, RO Erlendsdottir, H Hopia, D Sharpe, PD Williams, I Rydström, J Case-Smith, K Reichenberg, JS LeBovidge, J Cohen, BL Cohen, JC Nunnally   +50 more
core   +2 more sources

Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This study evaluated long‐term safety and efficacy in patients with moderate‐to‐severe atopic dermatitis. Patients with and without previous nemolizumab experience received nemolizumab 30 mg Q4W plus TCS/TCI. Nemolizumab was well‐tolerated through 104 weeks with clinically meaningful improvements in disease signs and symptoms.
Matthias Augustin, Marie Tauber, Robert Sidbury, Jonathan I. Silverberg, Kim A. Papp, Diamant Thaçi, Marjolein S. De Bruin‐Weller, Adam Reich, Ketty Peris, Kirk Barber, Ryszard Galus, Andrzej Kaszuba, Matthew Zirwas, Walter K. Nahm, Gretel Trullenque, Laura Maintz, Sady Alpizar, Sang Wook Son, Vivian Laquer, Linda Stein Gold, Soo Yeon Cheong, Anna Ryzhkova, Agnes Drahos, Liliana Ulianov, Christophe Piketty   +24 more
wiley   +1 more source

Conjunctivitis: Types, Clinical Manifestation and Management

JLUMHS
This narrative review analyses the different types, clinical manifestations, and management strategies for conjunctivitis to facilitate accurate diagnosis and treatment planning.
Mehwish Rubab, Sana Zahoor, Saba Ashraf
doaj   +1 more source